glp-1 and skin sensitivity Hypersensitivity to glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like rash to dulaglutide literature review - Bianchi - 2024 - JEADV Clinical Practice Allodynia: Causes, Management, and the

In PsA, insulin resistance has been associated with higher disease activity, greater pain burden, and reduced therapeutic responsiveness, reinforcing the rationale for metabolic interventions as part of a disease-modifying strategy (29)

Answer: Published studies report few side effects, but BPC-157 is not FDA-approved and human safety data are limited, so it should be used only under medical supervision with a full medication review

Her approach ensures that GLP-1 therapy addresses the underlying physiology behind each patient's weight and metabolic profile

This could be a protective negative feedback loop to prevent energy utilization getting out of hand if the insulin signal is too strong